Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral m…

Biotechnology

US, Menlo Park [HQ]

Analysts
Dividend Payments
Government Awards
Insiders
Lobbying Expenses
Segment Revenues
Shareholder Structure
Supply / Portfolio
Valuation Models [Soon]

Earnings Call Transcripts

Earnings Call · Transcripts · Speakers

This analysis tool shows transcript versions of the official earnings calls hosted by Corcept Therapeutics Incorporated

Click To Read:

Earnings Call Transcript for Q3 | Oct. 30, 2024 Earnings Call Transcript for Q2 | July 29, 2024 Earnings Call Transcript for Q1 | May 1, 2024

Earnings Call Transcripts

Q3 | Oct. 30, 2024 Q2 | July 29, 2024 Q1 | May 1, 2024

Peer Group

Sorry! None of CORT's peers has listed transcripts.

SEC Reader

The document search tool might be interesting as well.
Give it a try, to quickly access SEC Filings-

10-K · 10-Q · DEF 14A · S-4

Upcoming Transcript Tools

Full Text Search - Across All Transcripts
Detail Speaker Profiles
Non-US Transcripts